Utilize este identificador para referenciar este registo: https://hdl.handle.net/1822/57877

Registo completo
Campo DCValorIdioma
dc.contributor.authorMarote, Anapor
dc.contributor.authorPomeshchik, Yuriypor
dc.contributor.authorCollin, Annapor
dc.contributor.authorGoldwurm, Stefanopor
dc.contributor.authorLamas, Nuno J.por
dc.contributor.authorPinto, Luísapor
dc.contributor.authorSalgado, A. J.por
dc.contributor.authorRoybon, Laurentpor
dc.date.accessioned2019-01-07T17:10:43Z-
dc.date.available2019-01-07T17:10:43Z-
dc.date.issued2018-
dc.identifier.citationMarote, A., Pomeshchik, Y., Collin, A., Goldwurm, S., et. al.(2018). Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p. G2019S mutation in the LRRK2 gene. Stem cell research, 28, 44-47por
dc.identifier.issn1873-5061-
dc.identifier.urihttps://hdl.handle.net/1822/57877-
dc.description.abstractThe leucine-rich repeat kinase 2 (LRRK2) p.G2019S mutation is the most common genetic cause of Parkinson's disease (PD). An induced pluripotent stem cell (iPSC) line CSC-41 was generated from a 75-year old patient diagnosed with PD caused by a p.G2019S mutation in LRRK2. Skin fibroblasts were reprogrammed using a non-integrating Sendai virus-based technology to deliver OCT3/4, SOX2, c-MYC and KLF4 transcription factors. The generated iPSC line exhibits expression of common pluripotency markers, differentiates into the three germ layers and has a normal karyotype. The iPSC line can be used to explore the association between LRRK2 mutation and PD.por
dc.description.sponsorshipWe are greatly thankful to AnnaKarin Olden and Marianne Juhlin, for their technical assistance and to the 'Cell Line and DNA Biobank from Patients affected by Genetic Diseases' (Istituto G. Gaslini, Genova, Italy) and the Parkinson Institute Biobank, members of the Telethon Network of Genetic Biobanks (http://biobanknetwork.telethon.it; project no. GTB12001) funded by Telethon Italy, for providing fibroblasts samples. This work was supported by the Strategic Research Environment MultiPark at Lund University, the strong research environment BAGADILICO (grant 349-2007-8626), the Swedish Parkinson Foundation (Parkinsonfonden, grant 889/16), the Swedish Research Council (grant 2015-03684 to LR) and Finnish Cultural Foundation (grant 00161167 to YP). We also acknowledge the Portuguese Foundation for Science and Technology for the doctoral fellowship - PDE/BDE/113598/2015 to AM and IF Starting and Development Grants to LP and AJS (IF/00111/2013 and IF/01079/2014), respectively.por
dc.language.isoengpor
dc.publisherElsevier 1por
dc.relationPDE/BDE/113598/2015-
dc.rightsopenAccesspor
dc.subjectAgedpor
dc.subjectAnimalspor
dc.subjectCell Culture Techniquespor
dc.subjectCell Linepor
dc.subjectFemalepor
dc.subjectHumanspor
dc.subjectInduced Pluripotent Stem Cellspor
dc.subjectLeucine-Rich Repeat Serine-Threonine Protein Kinase-2por
dc.subjectMicepor
dc.subjectMutationpor
dc.subjectParkinson Diseasepor
dc.titleGeneration of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 genepor
dc.typearticlepor
dc.peerreviewedyespor
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S187350611830028Xpor
oaire.citationStartPage44por
oaire.citationEndPage47por
oaire.citationVolume28por
dc.identifier.eissn1876-7753-
dc.identifier.doi10.1016/j.scr.2018.01.022por
dc.identifier.pmid29414418por
dc.subject.fosCiências Médicas::Medicina Básicapor
dc.description.publicationversioninfo:eu-repo/semantics/publishedVersionpor
dc.subject.wosScience & Technologypor
sdum.journalStem Cell Researchpor
Aparece nas coleções:ICVS - Artigos em revistas internacionais / Papers in international journals

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
Marote A CSC41.pdf1,85 MBAdobe PDFVer/Abrir

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID